Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Prostatic Neoplasms × Cholecalciferol × Clear all

Phase

Status

Completed 8 Recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vitamin D Deficiency 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Vitamin D3 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Pain 1 Neuroma 1 Musculoskeletal Diseases 1 Multiple Sclerosis, Relapsing-Remitting 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Insulin Resistance 1 Hematologic Neoplasms 1 Glioblastoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Cachexia 1

Interventions

Docetaxel 18 Radiosurgery 17 Radiotherapy 14 Androgen Antagonists 14 Leuprolide 11 bicalutamide 9 Goserelin 9 enzalutamide 8 Surveys and Questionnaires 8 Radiotherapy, Intensity-Modulated 7 Prednisone 7 Blood Specimen Collection 7 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Gonadotropin-Releasing Hormone 6 Triptorelin Pamoate 5 Multiparametric Magnetic Resonance Imaging 5 Brachytherapy 5 Abiraterone Acetate 5 Standard of Care 4 Positron Emission Tomography Computed Tomography 4 Metformin 4 Heavy Ion Radiotherapy 4 Exercise 4 Estramustine 4 pembrolizumab 3 luprolide acetate gel depot 3 darolutamide 3 cabazitaxel 3 abiraterone 3 Watchful Waiting 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00741364 2011-09-30

DProstate

University of Toronto

Phase 2 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡